Aurealis Therapeutics
Developer of a cell and gene therapy platform designed to heal multifactorial diseases. The company's platform facilitates a novel class of combination immunotherapy embedded in a single product that ...
Valuation
$0
Share Price
N/A
Total Raised
$40.3M
Last Round
N/A